Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies

Alzheimer's and Dementia

Volumn 5, Issue 2, 2009, Pages 128-129

  Sabbagh, Marwan N ^a   Tariot, Pierre N ^b  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b BANNER ALZHEIMER S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CLINICAL RESEARCH; DISEASE COURSE; DISEASE REGISTRY; EDITORIAL; FAMILY HISTORY; GENOTYPE; HIGH RISK POPULATION; PATIENT PARTICIPATION; PRIORITY JOURNAL; RISK FACTOR;

ALZHEIMER DISEASE; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; HEALTH POLICY; NATIONAL HEALTH PROGRAMS; PATIENT SELECTION; PROSPECTIVE STUDIES; REGISTRIES; UNITED STATES;

EID: 62949188409     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2009.01.018     Document Type: Editorial

References (10)

1. Khatchaturian Z.S., Petersen R.C., Gauthier S., Buckholtz N., Corey-Bloom J., Evans B., et al. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement 5 (2009) 85-92
2. Kivipelto M., Ngandu T., Laatikainen T., Winblad B., Soininen H., and Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5 (2006) 735-741
3. Shankle W.R., and Amen D.G. Preventing Alzheimer's (2004), Berkley Publishing, New York p. 116-7
4. Scarmeas N., Stern Y., Tang M.S., Mayeux R., and Luchsinger J.A. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59 (2006) 912-921
5. Iqbal K., Chohan M.O., and Grundke-Iqbal I. Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease. J Alzheimers Dis 15 (2008) 339-345
6. Risner M.E., Saunders A.M., Altman J.F., Ormandy G.C., Craft S., Foley I.M., et al. Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenom J 6 (2006) 246-254
7. Heyman A., Fillenbaum G.G., and Mirra S.S. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical, neuropsychological, and neuropathological components. Aging (Milano) 2 (1990) 415-424
8. Fillenbaum G.G., van Belle G., Morris J.C., Mohs R.C., Mirra S.S., Davis P.C., et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimers Dement 4 (2008) 96-109
9. Tariot P.N., Sabbagh M., Holt C., Yaari R., Jakimovich L., and Keppler J. Arizona Alzheimer Research Registry part one: rationale and design. Alzheimers Dement 4 Suppl. 2 (2008) T790
10. Holt C.J., Tariot P.N., Sabbagh M., Yaari R., Jakimovich L., Westlund J., et al. Arizona Alzheimer's Research Registry: part 2, progress and findings from year one. Alzheimers Dement 4 Suppl 2 (2008) T782